Specific Uptake of Lipid-Antibody-Functionalized LbL Microcarriers by Cells
The modular construction of Layer-by-Layer biopolymer microcarriers facilitates a highly specific design of drug delivery systems. A supported lipid bilayer (SLB) contributes to biocompatibility and protection of sensitive active agents. The addition of a lipid anchor equipped with PEG (shielding fr...
Gespeichert in:
Veröffentlicht in: | Biomacromolecules 2016-11, Vol.17 (11), p.3672-3682 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3682 |
---|---|
container_issue | 11 |
container_start_page | 3672 |
container_title | Biomacromolecules |
container_volume | 17 |
creator | Göse, Martin Scheffler, Kira Reibetanz, Uta |
description | The modular construction of Layer-by-Layer biopolymer microcarriers facilitates a highly specific design of drug delivery systems. A supported lipid bilayer (SLB) contributes to biocompatibility and protection of sensitive active agents. The addition of a lipid anchor equipped with PEG (shielding from opsonins) and biotin (attachment of exchangeable outer functional molecules) enhances the microcarrier functionality even more. However, a homogeneously assembled supported lipid bilayer is a prerequisite for a specific binding of functional components. Our investigations show that a tightly packed SLB improves the efficiency of functional components attached to the microcarrier’s surface, as illustrated with specific antibodies in cellular application. Only a low quantity of antibodies is needed to obtain improved cellular uptake rates independent from cell type as compared to an antibody-functionalized loosely packed lipid bilayer or directly assembled antibody onto the multilayer. A fast disassembly of the lipid bilayer within endolysosomes exposing the underlying drug delivering multilayer structure demonstrates the suitability of LbL-microcarriers as a multifunctional drug delivery system. |
doi_str_mv | 10.1021/acs.biomac.6b01159 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835438412</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835438412</sourcerecordid><originalsourceid>FETCH-LOGICAL-a342t-8f1d1c3b4535e4644f2139fa93be739995de1ad28089b94430243503cb8228043</originalsourceid><addsrcrecordid>eNp9kL1OwzAURi0EoqXwAgwoI0uCf5N4rCoKiCAG6GzZjiO5pHGwk6E8PS4pjEz36up8n64OANcIZghidCd1yJR1O6mzXEGEGD8Bc8RwntIc4tOfnaVFwYsZuAhhCyHkhLJzMMNFQWlelnPw_NYbbRurk00_yA-TuCapbG_rdNkNVrl6n67HTg_WdbK1X6ZOKlUlL1Z7p6X31viQqH2yMm0bLsFZI9tgro5zATbr-_fVY1q9PjytllUqCcVDWjaoRpooyggzNKe0wYjwRnKiTEE456w2SNa4hCVXnFICMSUMEq1KHI-ULMDt1Nt79zmaMIidDTp-IDvjxiBQSRglJUU4onhC478heNOI3tud9HuBoDhIFFGimCSKo8QYujn2j2pn6r_Ir7UIZBNwCG_d6KOb8F_jN7CGfa8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835438412</pqid></control><display><type>article</type><title>Specific Uptake of Lipid-Antibody-Functionalized LbL Microcarriers by Cells</title><source>ACS Publications</source><source>MEDLINE</source><creator>Göse, Martin ; Scheffler, Kira ; Reibetanz, Uta</creator><creatorcontrib>Göse, Martin ; Scheffler, Kira ; Reibetanz, Uta</creatorcontrib><description>The modular construction of Layer-by-Layer biopolymer microcarriers facilitates a highly specific design of drug delivery systems. A supported lipid bilayer (SLB) contributes to biocompatibility and protection of sensitive active agents. The addition of a lipid anchor equipped with PEG (shielding from opsonins) and biotin (attachment of exchangeable outer functional molecules) enhances the microcarrier functionality even more. However, a homogeneously assembled supported lipid bilayer is a prerequisite for a specific binding of functional components. Our investigations show that a tightly packed SLB improves the efficiency of functional components attached to the microcarrier’s surface, as illustrated with specific antibodies in cellular application. Only a low quantity of antibodies is needed to obtain improved cellular uptake rates independent from cell type as compared to an antibody-functionalized loosely packed lipid bilayer or directly assembled antibody onto the multilayer. A fast disassembly of the lipid bilayer within endolysosomes exposing the underlying drug delivering multilayer structure demonstrates the suitability of LbL-microcarriers as a multifunctional drug delivery system.</description><identifier>ISSN: 1525-7797</identifier><identifier>EISSN: 1526-4602</identifier><identifier>DOI: 10.1021/acs.biomac.6b01159</identifier><identifier>PMID: 27744688</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Biocompatible Materials - chemical synthesis ; Biocompatible Materials - chemistry ; Biocompatible Materials - therapeutic use ; Biopolymers - chemistry ; Biopolymers - therapeutic use ; Biotin - chemistry ; Biotin - therapeutic use ; Drug Carriers - chemistry ; Drug Delivery Systems ; Humans ; Lipid Bilayers - chemical synthesis ; Lipid Bilayers - chemistry ; Lipid Bilayers - therapeutic use ; Lysosomes - chemistry</subject><ispartof>Biomacromolecules, 2016-11, Vol.17 (11), p.3672-3682</ispartof><rights>Copyright © 2016 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a342t-8f1d1c3b4535e4644f2139fa93be739995de1ad28089b94430243503cb8228043</citedby><cites>FETCH-LOGICAL-a342t-8f1d1c3b4535e4644f2139fa93be739995de1ad28089b94430243503cb8228043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.biomac.6b01159$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.biomac.6b01159$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27744688$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Göse, Martin</creatorcontrib><creatorcontrib>Scheffler, Kira</creatorcontrib><creatorcontrib>Reibetanz, Uta</creatorcontrib><title>Specific Uptake of Lipid-Antibody-Functionalized LbL Microcarriers by Cells</title><title>Biomacromolecules</title><addtitle>Biomacromolecules</addtitle><description>The modular construction of Layer-by-Layer biopolymer microcarriers facilitates a highly specific design of drug delivery systems. A supported lipid bilayer (SLB) contributes to biocompatibility and protection of sensitive active agents. The addition of a lipid anchor equipped with PEG (shielding from opsonins) and biotin (attachment of exchangeable outer functional molecules) enhances the microcarrier functionality even more. However, a homogeneously assembled supported lipid bilayer is a prerequisite for a specific binding of functional components. Our investigations show that a tightly packed SLB improves the efficiency of functional components attached to the microcarrier’s surface, as illustrated with specific antibodies in cellular application. Only a low quantity of antibodies is needed to obtain improved cellular uptake rates independent from cell type as compared to an antibody-functionalized loosely packed lipid bilayer or directly assembled antibody onto the multilayer. A fast disassembly of the lipid bilayer within endolysosomes exposing the underlying drug delivering multilayer structure demonstrates the suitability of LbL-microcarriers as a multifunctional drug delivery system.</description><subject>Biocompatible Materials - chemical synthesis</subject><subject>Biocompatible Materials - chemistry</subject><subject>Biocompatible Materials - therapeutic use</subject><subject>Biopolymers - chemistry</subject><subject>Biopolymers - therapeutic use</subject><subject>Biotin - chemistry</subject><subject>Biotin - therapeutic use</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Delivery Systems</subject><subject>Humans</subject><subject>Lipid Bilayers - chemical synthesis</subject><subject>Lipid Bilayers - chemistry</subject><subject>Lipid Bilayers - therapeutic use</subject><subject>Lysosomes - chemistry</subject><issn>1525-7797</issn><issn>1526-4602</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kL1OwzAURi0EoqXwAgwoI0uCf5N4rCoKiCAG6GzZjiO5pHGwk6E8PS4pjEz36up8n64OANcIZghidCd1yJR1O6mzXEGEGD8Bc8RwntIc4tOfnaVFwYsZuAhhCyHkhLJzMMNFQWlelnPw_NYbbRurk00_yA-TuCapbG_rdNkNVrl6n67HTg_WdbK1X6ZOKlUlL1Z7p6X31viQqH2yMm0bLsFZI9tgro5zATbr-_fVY1q9PjytllUqCcVDWjaoRpooyggzNKe0wYjwRnKiTEE456w2SNa4hCVXnFICMSUMEq1KHI-ULMDt1Nt79zmaMIidDTp-IDvjxiBQSRglJUU4onhC478heNOI3tud9HuBoDhIFFGimCSKo8QYujn2j2pn6r_Ir7UIZBNwCG_d6KOb8F_jN7CGfa8</recordid><startdate>20161114</startdate><enddate>20161114</enddate><creator>Göse, Martin</creator><creator>Scheffler, Kira</creator><creator>Reibetanz, Uta</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20161114</creationdate><title>Specific Uptake of Lipid-Antibody-Functionalized LbL Microcarriers by Cells</title><author>Göse, Martin ; Scheffler, Kira ; Reibetanz, Uta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a342t-8f1d1c3b4535e4644f2139fa93be739995de1ad28089b94430243503cb8228043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biocompatible Materials - chemical synthesis</topic><topic>Biocompatible Materials - chemistry</topic><topic>Biocompatible Materials - therapeutic use</topic><topic>Biopolymers - chemistry</topic><topic>Biopolymers - therapeutic use</topic><topic>Biotin - chemistry</topic><topic>Biotin - therapeutic use</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Delivery Systems</topic><topic>Humans</topic><topic>Lipid Bilayers - chemical synthesis</topic><topic>Lipid Bilayers - chemistry</topic><topic>Lipid Bilayers - therapeutic use</topic><topic>Lysosomes - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Göse, Martin</creatorcontrib><creatorcontrib>Scheffler, Kira</creatorcontrib><creatorcontrib>Reibetanz, Uta</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomacromolecules</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Göse, Martin</au><au>Scheffler, Kira</au><au>Reibetanz, Uta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Specific Uptake of Lipid-Antibody-Functionalized LbL Microcarriers by Cells</atitle><jtitle>Biomacromolecules</jtitle><addtitle>Biomacromolecules</addtitle><date>2016-11-14</date><risdate>2016</risdate><volume>17</volume><issue>11</issue><spage>3672</spage><epage>3682</epage><pages>3672-3682</pages><issn>1525-7797</issn><eissn>1526-4602</eissn><abstract>The modular construction of Layer-by-Layer biopolymer microcarriers facilitates a highly specific design of drug delivery systems. A supported lipid bilayer (SLB) contributes to biocompatibility and protection of sensitive active agents. The addition of a lipid anchor equipped with PEG (shielding from opsonins) and biotin (attachment of exchangeable outer functional molecules) enhances the microcarrier functionality even more. However, a homogeneously assembled supported lipid bilayer is a prerequisite for a specific binding of functional components. Our investigations show that a tightly packed SLB improves the efficiency of functional components attached to the microcarrier’s surface, as illustrated with specific antibodies in cellular application. Only a low quantity of antibodies is needed to obtain improved cellular uptake rates independent from cell type as compared to an antibody-functionalized loosely packed lipid bilayer or directly assembled antibody onto the multilayer. A fast disassembly of the lipid bilayer within endolysosomes exposing the underlying drug delivering multilayer structure demonstrates the suitability of LbL-microcarriers as a multifunctional drug delivery system.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>27744688</pmid><doi>10.1021/acs.biomac.6b01159</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1525-7797 |
ispartof | Biomacromolecules, 2016-11, Vol.17 (11), p.3672-3682 |
issn | 1525-7797 1526-4602 |
language | eng |
recordid | cdi_proquest_miscellaneous_1835438412 |
source | ACS Publications; MEDLINE |
subjects | Biocompatible Materials - chemical synthesis Biocompatible Materials - chemistry Biocompatible Materials - therapeutic use Biopolymers - chemistry Biopolymers - therapeutic use Biotin - chemistry Biotin - therapeutic use Drug Carriers - chemistry Drug Delivery Systems Humans Lipid Bilayers - chemical synthesis Lipid Bilayers - chemistry Lipid Bilayers - therapeutic use Lysosomes - chemistry |
title | Specific Uptake of Lipid-Antibody-Functionalized LbL Microcarriers by Cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T16%3A11%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Specific%20Uptake%20of%20Lipid-Antibody-Functionalized%20LbL%20Microcarriers%20by%20Cells&rft.jtitle=Biomacromolecules&rft.au=Go%CC%88se,%20Martin&rft.date=2016-11-14&rft.volume=17&rft.issue=11&rft.spage=3672&rft.epage=3682&rft.pages=3672-3682&rft.issn=1525-7797&rft.eissn=1526-4602&rft_id=info:doi/10.1021/acs.biomac.6b01159&rft_dat=%3Cproquest_cross%3E1835438412%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835438412&rft_id=info:pmid/27744688&rfr_iscdi=true |